SCHEMBL22148591

SCHEMBL22148591

c1ccc(-c2cc(-c3ccccc3-c3c(-n4c5ccccc5c5ccccc54)c(-n4c5ccccc5c5ccccc54)nc(-n4c5ccccc5c5ccccc54)c3-n3c4ccccc4c4ccccc43)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.39
KMT2A Q03164 8/20 0.39
MAPT P10636 7/20 0.39
HPGD P15428 6/20 0.39
ALDH1A1 P00352 5/20 0.39
NTSR1 P30989 1/20 0.39
LMNA P02545 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
MAPK10 P53779 1/20 0.38
ADORA2A P29274 2/20 0.37
ADORA1 P30542 2/20 0.37
NPSR1 Q6W5P4 3/20 0.36
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
AGTR1 P30556 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22148759 0.92 MEN1 (0.37) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30709437 0.92 MEN1 (0.37) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL22148706 0.91 MAPT (0.33) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL22148721 0.91 MAOA (0.35) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30709402 0.91 MEN1 (0.37) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL22148532 0.91 MAOA (0.35) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL22148775 0.90 CYP19A1 (0.35) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21888637 0.90 MEN1 (0.43) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30709642 0.89 ABCG2 (0.36) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30709517 0.89 TOP1 (0.38) MEN1KMT2AMAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 MEN1 2193/4885KMT2A 4367/4885MAPT 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.